Resideo Technologies filings document operating results, segment performance, material agreements, capital structure, governance, and shareholder voting matters for a NYSE-listed manufacturer, developer, and distributor of sensing and controls products. The company's disclosures cover Products & Solutions and ADI Global Distribution, including financial results releases, proxy governance materials, executive compensation matters, and common stock registration details.
Material-event filings also record financing and agreement activity, including credit agreement amendments and the completed termination of a legacy Honeywell indemnification and reimbursement arrangement. Proxy and 8-K filings address board and compensation matters, annual shareholder votes, and formal disclosures tied to Resideo's business structure and capital obligations.
Resideo Technologies completed a transaction that terminated a long‑standing indemnification and reimbursement arrangement with Honeywell in exchange for a one‑time $1,590,000,000 cash payment. The termination eliminated Resideo’s obligation to make annual payments to Honeywell of up to $140 million through year‑end 2043 and removed the affirmative and negative covenants under that agreement, subject only to limited provisions that survived termination.
To fund part of the payment, Resideo amended its existing credit facilities and obtained incremental senior secured term loans totaling $1.225 billion with a seven‑year maturity and interest at Term SOFR plus 2.00%. The amendment also raised the interest on certain existing term B tranches from Term SOFR plus 1.75% to Term SOFR plus 2.00%, increased capacity to incur incremental debt, temporarily relaxed the total leverage covenant to 4.00:1.00 for two upcoming test periods, and permits future revolver refinancings.
Resideo Technologies insider transaction summary The Form 4 reports that CD&R-affiliated entities, identified as a director and greater-than-10% owner, purchased a total of 1,246,123 shares of Resideo Technologies, Inc. (REZI) across transactions dated 08/08/2025, 08/11/2025 and 08/12/2025. The filing shows weighted-average prices for the five reported lots of $27.3003, $27.3366, $30.0345, $30.9423 and $31.4902, and footnotes disclose the price ranges for each lot.
Following these purchases the reporting persons' disclosed beneficial ownership rose to 11,478,543 shares. The securities are owned directly by CD&R Channel Holdings II, L.P., with CD&R Investment Associates XII, Ltd. and CD&R Associates XII, L.P. identified as affiliated entities that may be deemed to beneficially own the reported securities.
Resideo Technologies insider filing: Michael Carlet, the company's Chief Financial Officer, reported a purchase of 1,540 shares of Resideo Technologies, Inc. (REZI) on 08/09/2025 at a reported price of $27.37 per share. Following the transaction his beneficial ownership is reported as 160,861 shares. The transaction is recorded on a Form 4 and is shown with transaction code F.
Resideo Technologies, Inc. filed a Form 144 reporting a proposed sale of 35,398 common shares through Morgan Stanley Smith Barney on 08/12/2025. The filing lists an aggregate market value of $1,108,378.64 against 148,763,403 shares outstanding, and names the NYSE as the exchange. The notice shows the shares were acquired by a stock option exercise on 08/12/2025 and payment was made in cash.
The filer indicates there were no securities sold by the person in the past three months. Other identifying details for the filer and the issuer (such as specific names or relationship descriptions) are not provided in the text of this filing. The form includes the standard representation that the seller is not aware of undisclosed material adverse information.
Resideo Technologies (REZI) filed a Form 144 disclosing a proposed sale of 47,500 shares of common stock, with an aggregate market value of $1,486,279.75, to be sold on the NYSE through Morgan Stanley Smith Barney LLC with an approximate sale date of 08/12/2025. The filing shows total shares outstanding of 148,763,403, and states there were no securities sold in the past three months by the selling person.
The securities offered were received as restricted stock in three lots dated 02/18/2023 (19,446 shares), 02/18/2024 (2,592 shares) and 02/09/2025 (25,462 shares). The filer affirms they are not aware of any undisclosed material adverse information about the issuer.
Boston Partners filed a Schedule 13G/A reporting beneficial ownership of Resideo Technologies common stock. The firm reports ownership of 8,394,667 shares, representing 5.65% of the outstanding class, and may be deemed a beneficial owner under the Exchange Act.
The filing shows Boston Partners has sole voting power over 6,669,489 shares and sole dispositive power over 8,394,667 shares. The shares are held in discretionary client accounts and the filer certifies the holdings were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control.